PREGNANCY IN THALASSEMIA

Therapeutic advances, including the availability of oral iron chelators and new non-invasive methods for early detection and treatment of iron overload, have significantly improved the life expectancy and quality of life of patients with thalassemia, with a consequent increase in their reproductive...

Full description

Saved in:
Bibliographic Details
Main Authors: Raffaella Origa, Federica Comitini
Format: Article
Language:English
Published: PAGEPress Publications 2019-02-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Online Access:https://www.mjhid.org/index.php/mjhid/article/view/3775
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846096367259222016
author Raffaella Origa
Federica Comitini
author_facet Raffaella Origa
Federica Comitini
author_sort Raffaella Origa
collection DOAJ
description Therapeutic advances, including the availability of oral iron chelators and new non-invasive methods for early detection and treatment of iron overload, have significantly improved the life expectancy and quality of life of patients with thalassemia, with a consequent increase in their reproductive potential and desire to have children. Hundreds of pregnancies have been reported so far, highlighting that women carefully managed during preconception usually carry out a successful gestation and labour, both in case of spontaneous conception and use of assisted reproductive techniques. A multidisciplinary team including a cardiologist, an endocrinologist and a gynaecologist, with the supervision of an expert in beta-thalassemia should be involved.  During pregnancy, a close follow-up of maternal disorders and of the baby's status is recommended. Haemoglobin should be maintained over 10 g/dL to to allow normal foetal growth. Chelators are not recommended during pregnancy; nevertheless, it may reasonable to consider restarting chelation therapy with desferrioxamine towards the end of the second trimester when the potential benefit outweighs the potential foetal risk. Women with non-transfusion-dependent thalassemia who have never previously been transfused or who have received only minimal transfusion therapy are at risk of severe alloimmune anaemia if blood transfusions are required during pregnancy. Since pregnancy increases the risk of thrombosis three-fold to four-fold and thalassemia is also a hypercoagulable state, the recommendation is to keep women who are at higher risk -such as those who are not regularly transfused and those splenectomised-  on prophylaxis during pregnancy and during the postpartum period.   Keywords:Pregnancy, Thalassemia major, Thalassemia intermedia, Haemoglobin H disease, Counselling
format Article
id doaj-art-eaf77b686e664a39b4f2887a04cb217c
institution Kabale University
issn 2035-3006
language English
publishDate 2019-02-01
publisher PAGEPress Publications
record_format Article
series Mediterranean Journal of Hematology and Infectious Diseases
spelling doaj-art-eaf77b686e664a39b4f2887a04cb217c2025-01-02T06:58:56ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062019-02-01111e2019019e201901910.4084/mjhid.2019.0193775PREGNANCY IN THALASSEMIARaffaella Origa0Federica Comitini1Clinica Pediatrica 2°, Dipartimento di Sanità Pubblica, Medicina Clinica e Molecolare, Università di Cagliari, Ospedale Regionale per le Microcitemie, ASL 8 Cagliari, ItalyUniversità di CagliariTherapeutic advances, including the availability of oral iron chelators and new non-invasive methods for early detection and treatment of iron overload, have significantly improved the life expectancy and quality of life of patients with thalassemia, with a consequent increase in their reproductive potential and desire to have children. Hundreds of pregnancies have been reported so far, highlighting that women carefully managed during preconception usually carry out a successful gestation and labour, both in case of spontaneous conception and use of assisted reproductive techniques. A multidisciplinary team including a cardiologist, an endocrinologist and a gynaecologist, with the supervision of an expert in beta-thalassemia should be involved.  During pregnancy, a close follow-up of maternal disorders and of the baby's status is recommended. Haemoglobin should be maintained over 10 g/dL to to allow normal foetal growth. Chelators are not recommended during pregnancy; nevertheless, it may reasonable to consider restarting chelation therapy with desferrioxamine towards the end of the second trimester when the potential benefit outweighs the potential foetal risk. Women with non-transfusion-dependent thalassemia who have never previously been transfused or who have received only minimal transfusion therapy are at risk of severe alloimmune anaemia if blood transfusions are required during pregnancy. Since pregnancy increases the risk of thrombosis three-fold to four-fold and thalassemia is also a hypercoagulable state, the recommendation is to keep women who are at higher risk -such as those who are not regularly transfused and those splenectomised-  on prophylaxis during pregnancy and during the postpartum period.   Keywords:Pregnancy, Thalassemia major, Thalassemia intermedia, Haemoglobin H disease, Counsellinghttps://www.mjhid.org/index.php/mjhid/article/view/3775Pregnancy, Thalassemia major, Thalassemia intermedia, Haemoglobin H disease, Counselling.
spellingShingle Raffaella Origa
Federica Comitini
PREGNANCY IN THALASSEMIA
Mediterranean Journal of Hematology and Infectious Diseases
Pregnancy, Thalassemia major, Thalassemia intermedia, Haemoglobin H disease, Counselling.
title PREGNANCY IN THALASSEMIA
title_full PREGNANCY IN THALASSEMIA
title_fullStr PREGNANCY IN THALASSEMIA
title_full_unstemmed PREGNANCY IN THALASSEMIA
title_short PREGNANCY IN THALASSEMIA
title_sort pregnancy in thalassemia
topic Pregnancy, Thalassemia major, Thalassemia intermedia, Haemoglobin H disease, Counselling.
url https://www.mjhid.org/index.php/mjhid/article/view/3775
work_keys_str_mv AT raffaellaoriga pregnancyinthalassemia
AT federicacomitini pregnancyinthalassemia